Skin necrosis is a well-recognized although rare complication of conti
nuous heparin therapy. We report the case of a 66-year-old diabetic wo
man with end-stage renal failure who received intermittent intravenous
heparin during hemodialysis. She developed severe necrotic cutaneous
ulcers over both legs, with typical histological findings. Thrombocyto
penia never occurred but platelet studies demonstrated enhanced aggreg
ation when heparin was added in vitro. Platelet-aggregating immunoglob
ulins produced in response to heparin can lead to thrombotic events. T
hrombocytopenia usually develops prior to the onset of cutaneous lesio
ns, but as in this case, may be absent. Heparin should be discontinued
when the condition is recognized. Unfortunately, a poor outcome is fr
equently observed.